July 28, 2001
Beckman Coulter Inc., a Fullerton provider of medical laboratory products, said net income for the second quarter rose 14% to $36.8 million, or 58 cents a share, from $32.4 million, or 53 cents a share, a year ago. Sales increased 6% to $496.4 million. Other Orange County company earnings: * Onyx Acceptance Corp., a Foothill Ranch automobile finance company, said second-quarter net income totaled $1.8 million, or 35 cents a share, up 13% from $1.
July 19, 2001
Medical device maker Beckman Coulter Inc. said it has acquired an Austrian company that will help Beckman customers automate processes in drug discovery, protein studies and genomics. The Fullerton company did not disclose the purchase price for Anthos Labtec Instruments G.m.b.H. in Salzburg. Beckman stock lost 4 cents to close at $44.66 a share on the New York Stock Exchange.
June 15, 2001 |
The chance that Bayer AG might announce an acquisition Thursday of Fullerton medical instruments maker Beckman Coulter Inc. evaporated when the German conglomerate's diagnostics unit said instead that it bought the rights to tests for HIV and hepatitis C from four rivals. Beckman's stock, which jumped as much as 10% on the acquisition rumors Wednesday, fell 20 cents Thursday to close at $39.81 a share on the New York Stock Exchange.
June 8, 2001 |
Medical instruments maker Beckman Coulter Inc. said it expects to raise about $200 million in a public offering of debt securities that can be converted to common stock. The Fullerton company intends to use the proceeds to refinance a portion of its existing borrowings. Beckman has bank debt of $893 million and expects to pay off $100 million of it by the end of the year. Beckman shares fell $1 on Thursday to close at $39 on the New York Stock Exchange.
May 1, 2001
Beckman Coulter Inc., Fullerton provider of medical instruments, reported first-quarter net income of $20.3 million, or 32 cents a share, which included a charge of $3.1 million for an accounting change. A year earlier, the company earned $21 million, or 35 cents a share. Sales declined to $432.7 million, from $434.4 million, as a strong dollar trimmed sales growth overseas, the company said.
March 25, 2001
George E. Bers, Edgar E. Vivanco and Albert R. Ziegler have been named presidents of new divisions at Beckman Coulter Inc. in Fullerton. Bers, who recently joined the company as vice president for bioresearch, was appointed president of the life science research division. The specialty testing division will be led by Vivanco, formerly senior vice president of the company's diagnostic development, corporate manufacturing & quality division. Ziegler will head the clinical diagnostics division.
March 20, 2001 |
Beckman Coulter Inc. said Monday its three-year chemistry agreement with Novation has been extended for an additional two years, which should generate an estimated $144 million more for the Fullerton company. Beckman said it will continue to provide Novation with chemistry, immunodiagnostic and automation products. The contract with Novation, a supply cost-management company based in Irving, Texas, will run through Dec. 31, 2002.
January 27, 2001
Beckman Coulter Inc. a Fullerton maker of medical instruments, said net income for the fourth quarter totaled $43 million, or 69 cents a share, an increase of 11% from $38.6 million, or 65 cents a share, a year ago. Sales increased 2% to $525.3 million. Net income for the year was up 18% to $125.5 million, or $2.03 a share, from $106 million, or $1.79 a share, for 1999. Sales rose 6% to $1.9 billion.
November 21, 2000 |
Beckman Coulter Inc. said Monday it received regulatory approval to market Access Testosterone, a test for total testosterone levels in human serum and plasma. Testosterone, which is found in men and women, helps build muscle, influences sex drive and stimulates production of red blood cells. The Fullerton company, which received approval by the Food and Drug Administration to market the test, said it will be available on the company's Access Immunoassay System.
November 15, 2000
Fullerton medical instruments maker Beckman Coulter Inc. said Tuesday that it has signed an agreement valued at $30 million to provide hematology instrument systems and related products to a New Jersey company. Beckman said in a news release that under terms of the five-year agreement, it will be the sole source of the equipment for Quest Diagnostics Inc., a Teterboro, N.J., provider of diagnostic testing, information and services.